Eyecelerator is back to kick off the ASCRS Annual Meeting. Eyecelerator@ASCRS will take place all day on April 4 at the Omni Boston Hotel at the Seaport. This year’s program is led by co-chairs John Berdahl, MD, and Julie Schallhorn, MD, and program director Gil Kliman, MD.
Mitchell Weikert, MD, told readers what he is excited for at the ASCRS Annual Meeting and gave an overview of the articles in the Cataract section.
Refractive Editor Karolinne Rocha, MD, previewed the articles in the section and shared what she is looking forward to at the ASCRS Annual Meeting.
The articles in the Cornea section represent a challenge to corneal specialists to develop the centers necessary to treat complex conditions or refer patients to providers who have. “Reading them made me feel a renewed energy and commitment to patient care, and I hope you feel the same,” said Cornea Editor Julie Schallhorn, MD.
Glaucoma Editor Manjool Shah, MD, reflected on the journey of his colleagues over the last 50 years and shared what readers can expect in the Glaucoma section of the issue.
Here is what attendees of the 2024 ASCRS Annual Meeting can expect April 5–8 in Boston, Massachusetts.
The ASCRS Foundation will host “Be the Change You Wish to See,” at the 2024 ASCRS Annual Meeting. The discussion will include lessons learned, current needs, and future opportunities for addressing blindness domestically and worldwide. The symposium will feature four sections, all moderated by ASCRS Foundation Board members.
Two cataract surgeons who have dealt with their share of short eyes reviewed their approach. They discussed their methods for lens selection and provided pearls on how to avoid complications like iris prolapse and effusions.
There has been controversy around ICL sizing and vault for a long time, according to some physicians. Three experts discussed the topic in this article.
Identifying and treating patients with limbal stem cell dysfunction or deficiency can be a challenging process. Several physicians discussed how they handle these patients, including which techniques are available for mild to more severe disease.